ARCH Venture Fund IX, L.P.

13F Holdings History for Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Symbol: LYEL on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001
Latest Disclosed Ownership: 2.76M shares
Security Ownership: 13%

ARCH Venture Fund IX, L.P. ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)

2025-11-14 - ARCH Venture Fund IX, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.76M shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL). This represents 13% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
ARCH Venture Fund IX, L.P.	13%		$44.8M	2.76M			$16.24	13G/A	9/30/2025	14 Nov 2025 16:30:04